ESR2 and breast carcinoma: In accordance with previously published data [15], correlation analysis of all breast cancer patients’ overall survival (OS) and receptor expression demonstrated that patients expressing high levels of ERβ mRNA had a better prognosis (Figure 2A), indicating the possibility that ERβ may exert similar effects also in TNBC.